Nocturnal Gamma-Hydroxybutyrate Reduces Cortisol-Awakening Response and Morning Kynurenine Pathway Metabolites in Healthy Volunteers

BACKGROUND: Gamma-hydroxybutyrate (GHB; or sodium oxybate) is an endogenous GHB-/gamma-aminobutyric acid (B) receptor agonist. It is approved for application in narcolepsy and has been proposed for the potential treatment of Alzheimer’s disease, Parkinson’s disease, fibromyalgia, and depression, all...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Neuropsychopharmacol
Main Authors: Dornbierer, D A, Boxler, M, Voegel, C D, Stucky, B, Steuer, A E, Binz, T M, Baumgartner, M R, Baur, D M, Quednow, B B, Kraemer, T, Seifritz, E, Landolt, H P, Bosch, O G
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Regular Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6822136/
https://ncbi.nlm.nih.gov/pubmed/31504554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyz047
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados